Clara Soh provides analysis for clients on the impact of legislation and regulation on business impacts.

She applies her background in economics, evidence-based medicine, and policy analysis to help quantify the costs and value of healthcare services to patients and society. Clara has expertise in advising payers, providers, and manufacturers understand and navigate the constantly shifting reimbursement environment.

Prior to joining Avalere, Clara was a senior director, Policy and Research, for Pharmaceutical Research and Manufacturers of America, conducting research and analysis around the value of prescription medicines and patient access. Prior to that, as a research associate at Kaiser Permanente Center for Health Research, she advised the U.S. Preventive Services Task Force on preventive health topics.

Clara has an MPA in health policy and management from New York University and a BS in molecular biophysics and biochemistry from Yale University.

Authored Content


The Substance Use Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, signed into law on October 24, 2018, takes aim at the opioid crisis from multiple angles.

Shift in clinical practice as far back as 30 years ago planted the seeds for the current opioid epidemic. New research by Avalere Health finds that between the mid-1980s and 1990s, individual pharmaceutical manufacturers, national scientific bodies, and professional societies began a push to treat pain more aggressively.

ICER’s reliance on the average number of FDA drug approvals to calculate budget impact thresholds leads to significant variability.

Maine had the greatest decline at 25% compared with the national average of 11%.

Avalere analysis finds that price of generic drugs has remained flat but the cost to seniors is increasing.

New research from Avalere Health finds 11 states and DC lack an adequate number of providers certified to prescribe buprenorphine, a medicine used to prevent relapse in people with opioid dependence.

Resource presents trends in opioid painkiller prescriptions and deaths due to misuse and abuse.